Retatrutide Half Life (Educational)

Retatrutide’s half life in humans is commonly reported as ~6 days (~144 hours). That long half life is one reason it’s often described as compatible with once weekly administration in research settings (not a recommendation).

Half life is a simple way to describe how long something tends to stay in the body under a simplified model.

• If something has a 6 day half life, then after about 6 days, roughly half remains.
• After another ~6 days (about 12 days total), roughly 25% remains.
• Then ~12.5%, ~6.25%, and so on.

This is a simplified model. Real biology can differ based on the person, the amount used, and how the body clears it.

1) Why it’s often described as “once weekly” in research

A longer half life usually means levels drop more slowly day to day. That tends to make weekly schedules feasible in clinical research.

2) Why levels can “build up” over the first few weeks

If some amount is still present when the next dose is taken, levels can accumulate until they reach a plateau.

Rule of thumb: steady state is often described as ~4–5 half lives. With a ~6 day half life, that’s roughly ~24–30 days (about ~4–5 weeks).

3) How long until it’s mostly “gone” (rough estimate)

Another common rule of thumb is that after ~5 half lives, only a small fraction remains (around ~3% under the simplified model). With a ~6 day half life, that’s roughly ~30 days.

Some modern peptide medicines are designed with structural changes that make them break down more slowly and/or leave the bloodstream more slowly. That’s one common way longer half lives are achieved.